Outset Medical, Inc. (OM) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US6901452069
Outset Medical, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 119.48 m USD |
| Gross profit | 46.75 m USD |
| Operating income | -66.71 m USD |
| EBIT | -66.98 m USD |
| Net income | -81.65 m USD |
| Diluted EPS – continuing operations | -5.37 USD |
Full history since 2017, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Outset Medical, Inc.
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
More stocks
- myNEWS Holdings Bhd (5275.KL)
- Huikwang (6508.TWO)
- Howteh Technology Co Ltd (3114.TWO)
- Showbox Corp (086980.KQ)
- Tacheng Real Estate Co Ltd (6171.TWO)
- FNS TECH. Co., Ltd (083500.KQ)
- Libertas 7 SA (LIB.MC)
- Soonest Express Co Ltd (2643.TWO)
- Gigastone Corporation (5262.TWO)
- Integrated Logistics Bhd (5614.KL)
- NutriBand Inc. (NTRB)
- Brazilian Critical Minerals Ltd (BCM.AX)
Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.